NASDAQ:PETQPetIQ Stock Price, Forecast & News

PetIQ's stock was trading at $22.59 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, PETQ stock has increased by 53.3% and is now trading at $34.63. View which stocks have been most impacted by Coronavirus.

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for PetIQ in the last year. There are currently 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for PetIQ.

PetIQ is scheduled to release its next quarterly earnings announcement on Wednesday, August 5th 2020. View our earnings forecast for PetIQ.

PetIQ Inc (NASDAQ:PETQ) released its quarterly earnings data on Thursday, May, 7th. The company reported $0.19 EPS for the quarter, beating the consensus estimate of $0.17 by $0.02. The firm earned $186.78 million during the quarter, compared to analysts' expectations of $176.52 million. PetIQ had a positive return on equity of 8.28% and a negative net margin of 2.03%. View PetIQ's earnings history.

4 brokerages have issued 12 month price targets for PetIQ's stock. Their forecasts range from $35.00 to $44.00. On average, they anticipate PetIQ's share price to reach $40.00 in the next year. This suggests a possible upside of 15.5% from the stock's current price. View analysts' price targets for PetIQ.

Media stories about PETQ stock have trended negative this week, InfoTrie reports. The research firm rates the sentiment of news coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. PetIQ earned a news sentiment score of -2.1 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news about PetIQ.

Some companies that are related to PetIQ include McKesson (MCK), AmerisourceBergen (ABC), Cardinal Health (CAH), Herbalife Nutrition (HLF), Nu Skin Enterprises (NUS), Trxade Group (TRXD), MultiCell Technologies (MEDS) and biOasis Technologies (BIOAF). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other PetIQ investors own include NVIDIA (NVDA), Micron Technology (MU), Alibaba Group (BABA), Intel (INTC), Advanced Micro Devices (AMD), CVS Health (CVS), Exelixis (EXEL), salesforce.com (CRM), Crispr Therapeutics (CRSP) and IBM (IBM).

(PETQ) raised $86 million in an initial public offering on Friday, July 21st 2017. The company issued 5,700,000 shares at a price of $14.00-$16.00 per share. Jefferies and William Blair served as the underwriters for the IPO and Oppenheimer, Raymond James and SunTrust Robinson Humphrey were co-managers.

PetIQ trades on the NASDAQ under the ticker symbol "PETQ."

Shares of PETQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of PETQ stock can currently be purchased for approximately $34.63.

PetIQ has a market capitalization of $982.80 million and generates $709.43 million in revenue each year. The company earns $-11,450,000.00 in net income (profit) each year or $1.07 on an earnings per share basis. PetIQ employs 1,866 workers across the globe.

The official website for PetIQ is www.petiq.com.

PetIQ's mailing address is 923 S. Bridgeway Pl., EAGLE ID, 83616. The company can be reached via phone at 208-939-8900 or via email at [email protected]